APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical API and Intermediates

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Pharmaceutical API and Intermediates Market Analysis and Forecast 2026-2032

22 December 2025210 pages

Choose your research edition.

Industry ResearchPharmaceutical API and Intermediates Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical API and Intermediates Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Pharmaceutical API and Intermediates Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical API and Intermediates Market Outlook and Growth Opportunities 2026218 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical API and Intermediates Market Analysis and Forecast 2026-2032210 pages · $4,950 USD

Market perspective

The global Pharmaceutical API and Intermediates market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

Pharmaceutical API and Intermediates's global sales reached XX (Tons) with a value of US$ XX Million, marking an change of XX% compared to the previous year. This performance has positioned Lonza as the global sales leader, a title it has maintained for several consecutive years. Notably, Lonza's performance in primary markets is also remarkable. In the Chinese market, sales were XX (Tons), a change of XX% from the previous year. In Europe, sales were XX (Tons), showing a year-on-year of XX%. In the US, sales were XX (Tons), a year-on-year change of XX%.

The major global manufacturers in the Pharmaceutical API and Intermediates market include Lonza, BASF, Patheon, Lianhetech, Jubilant, Catalent, ABA Chem, Actylis and Chiracon, etc. In 2025, the top three vendors accounted for approximately % of the revenue.

Read the full market overview

In terms of production side, this report researches the Pharmaceutical API and Intermediates production, growth rate, market share by manufacturers and by region (region level and country level), from 2021 to 2026, and forecast to 2032.

In terms of consumption side, this report focuses on the sales of Pharmaceutical API and Intermediates by region (region level and country level), by Company, by Type and by Application. from 2021 to 2026 and forecast to 2032.

This report presents an overview of global market for Pharmaceutical API and Intermediates, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Pharmaceutical API and Intermediates, also provides the consumption of main regions and countries. Of the upcoming market potential for Pharmaceutical API and Intermediates, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pharmaceutical API and Intermediates sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pharmaceutical API and Intermediates market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Pharmaceutical API and Intermediates sales, projected growth trends, production technology, application and end-user industry.

Pharmaceutical API and Intermediates Segment by Company

Lonza

BASF

Patheon

Lianhetech

Jubilant

Catalent

ABA Chem

Actylis

Chiracon

Codexis

CordenPharma

Granules India

Pfizer

Porton

Sanofi

Jiuzhou Pharmaceutical

Menohua

Puluo Pharmaceutical

Stanley

Tianyu shares

Huahai Pharmaceutical

Pharmaceutical API and Intermediates Segment by Type

API

Pharmaceutical Intermediates

Pharmaceutical API and Intermediates Segment by Application

Pharmaceutical

Feed

Food

Cosmetics

Health Products

Pharmaceutical API and Intermediates Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical API and Intermediates market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical API and Intermediates and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical API and Intermediates.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Pharmaceutical API and Intermediates production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.

Chapter 4: Sales (consumption), revenue of Pharmaceutical API and Intermediates in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 5: Detailed analysis of Pharmaceutical API and Intermediates manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmaceutical API and Intermediates sales, revenue, price, gross margin, and recent development, etc.

Chapter 9: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 10: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 11: China by type, by application, sales, and revenue for each segment.

Chapter 12: Asia (Excluding China) by type, by application and by region, sales, and revenue for each segment.

Chapter 13: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 14: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 15: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pharmaceutical API and Intermediates Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. API Major Manufacturers Table 3. Pharmaceutical Intermediates Major Manufacturers Table 4. Global Pharmaceutical API and Intermediates Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Pharmaceutical Major Manufacturers Table 6. Feed Major Manufacturers Table 7. Food Major Manufacturers Table 8. Cosmetics Major Manufacturers Table 9. Health Products Major Manufacturers Table 10. Pharmaceutical API and Intermediates Industry Trends Table 11. Pharmaceutical API and Intermediates Industry Drivers Table 12. Pharmaceutical API and Intermediates Industry Opportunities and Challenges Table 13. Pharmaceutical API and Intermediates Industry Restraints Table 14. Global Pharmaceutical API and Intermediates Production Growth Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Tons) Table 15. Global Pharmaceutical API and Intermediates Production by Region (2021-2026) & (Tons) Table 16. Global Pharmaceutical API and Intermediates Production by Region (2027-2032) & (Tons) Table 17. Global Pharmaceutical API and Intermediates Production Market Share by Region (2021-2026) Table 18. Global Pharmaceutical API and Intermediates Production Market Share by Region (2027-2032) Table 19. Global Pharmaceutical API and Intermediates Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global Pharmaceutical API and Intermediates Revenue by Region (2021-2026) & (US$ Million) Table 21. Global Pharmaceutical API and Intermediates Revenue by Region (2027-2032) & (US$ Million) Table 22. Global Pharmaceutical API and Intermediates Revenue Market Share by Region (2021-2026) Table 23. Global Pharmaceutical API and Intermediates Revenue Market Share by Region (2027-2032) Table 24. Global Pharmaceutical API and Intermediates Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Tons) Table 25. Global Pharmaceutical API and Intermediates Sales by Region (2021-2026) & (Tons) Table 26. Global Pharmaceutical API and Intermediates Sales by Region (2027-2032) & (Tons) Table 27. Global Pharmaceutical API and Intermediates Sales Market Share by Region (2021-2026) Table 28. Global Pharmaceutical API and Intermediates Sales Market Share by Region (2027-2032) Table 29. Global Pharmaceutical API and Intermediates Revenue by Manufacturers (US$ Million) & (2021-2026) Table 30. Global Pharmaceutical API and Intermediates Revenue Market Share by Manufacturers (2021-2026) Table 31. Global Pharmaceutical API and Intermediates Sales by Manufacturers (US$ Million) & (2021-2026) Table 32. Global Pharmaceutical API and Intermediates Sales Market Share by Manufacturers (2021-2026) Table 33. Global Pharmaceutical API and Intermediates Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 34. Global Pharmaceutical API and Intermediates Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 35. Global Pharmaceutical API and Intermediates Key Manufacturers Manufacturing Sites & Headquarters Table 36. Global Pharmaceutical API and Intermediates Manufacturers, Product Type & Application Table 37. Global Pharmaceutical API and Intermediates Manufacturers Commercialization Time Table 38. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 39. Global Pharmaceutical API and Intermediates by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 40. Global Pharmaceutical API and Intermediates Revenue by Type (2021-2026) & (US$ Million) Table 41. Global Pharmaceutical API and Intermediates Revenue by Type (2027-2032) & (US$ Million) Table 42. Global Pharmaceutical API and Intermediates Revenue Market Share by Type (2021-2026) Table 43. Global Pharmaceutical API and Intermediates Revenue Market Share by Type (2027-2032) Table 44. Global Pharmaceutical API and Intermediates Sales by Type (2021-2026) & (Tons) Table 45. Global Pharmaceutical API and Intermediates Sales by Type (2027-2032) & (Tons) Table 46. Global Pharmaceutical API and Intermediates Sales Market Share by Type (2021-2026) Table 47. Global Pharmaceutical API and Intermediates Sales Market Share by Type (2027-2032) Table 48. Global Pharmaceutical API and Intermediates Price by Type (2021-2026) & (US$/Ton) Table 49. Global Pharmaceutical API and Intermediates Price by Type (2027-2032) & (US$/Ton) Table 50. Global Pharmaceutical API and Intermediates Revenue by Application (2021-2026) & (US$ Million) Table 51. Global Pharmaceutical API and Intermediates Revenue by Application (2027-2032) & (US$ Million) Table 52. Global Pharmaceutical API and Intermediates Revenue Market Share by Application (2021-2026) Table 53. Global Pharmaceutical API and Intermediates Revenue Market Share by Application (2027-2032) Table 54. Global Pharmaceutical API and Intermediates Sales by Application (2021-2026) & (Tons) Table 55. Global Pharmaceutical API and Intermediates Sales by Application (2027-2032) & (Tons) Table 56. Global Pharmaceutical API and Intermediates Sales Market Share by Application (2021-2026) Table 57. Global Pharmaceutical API and Intermediates Sales Market Share by Application (2027-2032) Table 58. Global Pharmaceutical API and Intermediates Price by Application (2021-2026) & (US$/Ton) Table 59. Global Pharmaceutical API and Intermediates Price by Application (2027-2032) & (US$/Ton) Table 60. Lonza Company Information Table 61. Lonza Business Overview Table 62. Lonza Pharmaceutical API and Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 63. Lonza Pharmaceutical API and Intermediates Product Portfolio Table 64. Lonza Recent Development Table 65. BASF Company Information Table 66. BASF Business Overview Table 67. BASF Pharmaceutical API and Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 68. BASF Pharmaceutical API and Intermediates Product Portfolio Table 69. BASF Recent Development Table 70. Patheon Company Information Table 71. Patheon Business Overview Table 72. Patheon Pharmaceutical API and Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 73. Patheon Pharmaceutical API and Intermediates Product Portfolio Table 74. Patheon Recent Development Table 75. Lianhetech Company Information Table 76. Lianhetech Business Overview Table 77. Lianhetech Pharmaceutical API and Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 78. Lianhetech Pharmaceutical API and Intermediates Product Portfolio Table 79. Lianhetech Recent Development Table 80. Jubilant Company Information Table 81. Jubilant Business Overview Table 82. Jubilant Pharmaceutical API and Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 83. Jubilant Pharmaceutical API and Intermediates Product Portfolio Table 84. Jubilant Recent Development Table 85. Catalent Company Information Table 86. Catalent Business Overview Table 87. Catalent Pharmaceutical API and Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 88. Catalent Pharmaceutical API and Intermediates Product Portfolio Table 89. Catalent Recent Development Table 90. ABA Chem Company Information Table 91. ABA Chem Business Overview Table 92. ABA Chem Pharmaceutical API and Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 93. ABA Chem Pharmaceutical API and Intermediates Product Portfolio Table 94. ABA Chem Recent Development Table 95. Actylis Company Information Table 96. Actylis Business Overview Table 97. Actylis Pharmaceutical API and Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 98. Actylis Pharmaceutical API and Intermediates Product Portfolio Table 99. Actylis Recent Development Table 100. Chiracon Company Information Table 101. Chiracon Business Overview Table 102. Chiracon Pharmaceutical API and Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 103. Chiracon Pharmaceutical API and Intermediates Product Portfolio Table 104. Chiracon Recent Development Table 105. Codexis Company Information Table 106. Codexis Business Overview Table 107. Codexis Pharmaceutical API and Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 108. Codexis Pharmaceutical API and Intermediates Product Portfolio Table 109. Codexis Recent Development Table 110. CordenPharma Company Information Table 111. CordenPharma Business Overview Table 112. CordenPharma Pharmaceutical API and Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 113. CordenPharma Pharmaceutical API and Intermediates Product Portfolio Table 114. CordenPharma Recent Development Table 115. Granules India Company Information Table 116. Granules India Business Overview Table 117. Granules India Pharmaceutical API and Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 118. Granules India Pharmaceutical API and Intermediates Product Portfolio Table 119. Granules India Recent Development Table 120. Pfizer Company Information Table 121. Pfizer Business Overview Table 122. Pfizer Pharmaceutical API and Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 123. Pfizer Pharmaceutical API and Intermediates Product Portfolio Table 124. Pfizer Recent Development Table 125. Porton Company Information Table 126. Porton Business Overview Table 127. Porton Pharmaceutical API and Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 128. Porton Pharmaceutical API and Intermediates Product Portfolio Table 129. Porton Recent Development Table 130. Sanofi Company Information Table 131. Sanofi Business Overview Table 132. Sanofi Pharmaceutical API and Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 133. Sanofi Pharmaceutical API and Intermediates Product Portfolio Table 134. Sanofi Recent Development Table 135. Jiuzhou Pharmaceutical Company Information Table 136. Jiuzhou Pharmaceutical Business Overview Table 137. Jiuzhou Pharmaceutical Pharmaceutical API and Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 138. Jiuzhou Pharmaceutical Pharmaceutical API and Intermediates Product Portfolio Table 139. Jiuzhou Pharmaceutical Recent Development Table 140. Menohua Company Information Table 141. Menohua Business Overview Table 142. Menohua Pharmaceutical API and Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 143. Menohua Pharmaceutical API and Intermediates Product Portfolio Table 144. Menohua Recent Development Table 145. Puluo Pharmaceutical Company Information Table 146. Puluo Pharmaceutical Business Overview Table 147. Puluo Pharmaceutical Pharmaceutical API and Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 148. Puluo Pharmaceutical Pharmaceutical API and Intermediates Product Portfolio Table 149. Puluo Pharmaceutical Recent Development Table 150. Stanley Company Information Table 151. Stanley Business Overview Table 152. Stanley Pharmaceutical API and Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 153. Stanley Pharmaceutical API and Intermediates Product Portfolio Table 154. Stanley Recent Development Table 155. Tianyu shares Company Information Table 156. Tianyu shares Business Overview Table 157. Tianyu shares Pharmaceutical API and Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 158. Tianyu shares Pharmaceutical API and Intermediates Product Portfolio Table 159. Tianyu shares Recent Development Table 160. Huahai Pharmaceutical Company Information Table 161. Huahai Pharmaceutical Business Overview Table 162. Huahai Pharmaceutical Pharmaceutical API and Intermediates Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 163. Huahai Pharmaceutical Pharmaceutical API and Intermediates Product Portfolio Table 164. Huahai Pharmaceutical Recent Development Table 165. North America Pharmaceutical API and Intermediates Revenue by Type (2021-2026) & (US$ Million) Table 166. North America Pharmaceutical API and Intermediates Revenue by Type (2027-2032) & (US$ Million) Table 167. North America Pharmaceutical API and Intermediates Sales by Type (2021-2026) & (Tons) Table 168. North America Pharmaceutical API and Intermediates Sales by Type (2027-2032) & (Tons) Table 169. North America Pharmaceutical API and Intermediates Sales Price by Type (2021-2026) & (US$/Ton) Table 170. North America Pharmaceutical API and Intermediates Sales Price by Type (2027-2032) & (US$/Ton) Table 171. North America Pharmaceutical API and Intermediates Revenue by Application (2021-2026) & (US$ Million) Table 172. North America Pharmaceutical API and Intermediates Revenue by Application (2027-2032) & (US$ Million) Table 173. North America Pharmaceutical API and Intermediates Sales by Application (2021-2026) & (Tons) Table 174. North America Pharmaceutical API and Intermediates Sales by Application (2027-2032) & (Tons) Table 175. North America Pharmaceutical API and Intermediates Sales Price by Application (2021-2026) & (US$/Ton) Table 176. North America Pharmaceutical API and Intermediates Sales Price by Application (2027-2032) & (US$/Ton) Table 177. North America Pharmaceutical API and Intermediates Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 178. North America Pharmaceutical API and Intermediates Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 179. North America Pharmaceutical API and Intermediates Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 180. North America Pharmaceutical API and Intermediates Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 181. North America Pharmaceutical API and Intermediates Sales by Country (2021-2026) & (Tons) Table 182. North America Pharmaceutical API and Intermediates Sales by Country (2027-2032) & (Tons) Table 183. North America Pharmaceutical API and Intermediates Sales Price by Country (2021-2026) & (US$/Ton) Table 184. North America Pharmaceutical API and Intermediates Sales Price by Country (2027-2032) & (US$/Ton) Table 185. United States Pharmaceutical API and Intermediates Revenue (2021-2032) & (US$ Million) Table 186. Canada Pharmaceutical API and Intermediates Revenue (2021-2032) & (US$ Million) Table 187. Mexico Pharmaceutical API and Intermediates Revenue (2021-2032) & (US$ Million) Table 188. Europe Pharmaceutical API and Intermediates Revenue by Type (2021-2026) & (US$ Million) Table 189. Europe Pharmaceutical API and Intermediates Revenue by Type (2027-2032) & (US$ Million) Table 190. Europe Pharmaceutical API and Intermediates Sales by Type (2021-2026) & (Tons) Table 191. Europe Pharmaceutical API and Intermediates Sales by Type (2027-2032) & (Tons) Table 192. Europe Pharmaceutical API and Intermediates Sales Price by Type (2021-2026) & (US$/Ton) Table 193. Europe Pharmaceutical API and Intermediates Sales Price by Type (2027-2032) & (US$/Ton) Table 194. Europe Pharmaceutical API and Intermediates Revenue by Application (2021-2026) & (US$ Million) Table 195. Europe Pharmaceutical API and Intermediates Revenue by Application (2027-2032) & (US$ Million) Table 196. Europe Pharmaceutical API and Intermediates Sales by Application (2021-2026) & (Tons) Table 197. Europe Pharmaceutical API and Intermediates Sales by Application (2027-2032) & (Tons) Table 198. Europe Pharmaceutical API and Intermediates Sales Price by Application (2021-2026) & (US$/Ton) Table 199. Europe Pharmaceutical API and Intermediates Sales Price by Application (2027-2032) & (US$/Ton) Table 200. Europe Pharmaceutical API and Intermediates Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 201. Europe Pharmaceutical API and Intermediates Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 202. Europe Pharmaceutical API and Intermediates Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 203. Europe Pharmaceutical API and Intermediates Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 204. Europe Pharmaceutical API and Intermediates Sales by Country (2021-2026) & (Tons) Table 205. Europe Pharmaceutical API and Intermediates Sales by Country (2027-2032) & (Tons) Table 206. Europe Pharmaceutical API and Intermediates Sales Price by Country (2021-2026) & (US$/Ton) Table 207. Europe Pharmaceutical API and Intermediates Sales Price by Country (2027-2032) & (US$/Ton) Table 208. Germany Pharmaceutical API and Intermediates Revenue (2021-2032) & (US$ Million) Table 209. France Pharmaceutical API and Intermediates Revenue (2021-2032) & (US$ Million) Table 210. U.K. Pharmaceutical API and Intermediates Revenue (2021-2032) & (US$ Million) Table 211. Italy Pharmaceutical API and Intermediates Revenue (2021-2032) & (US$ Million) Table 212. Russia Pharmaceutical API and Intermediates Revenue (2021-2032) & (US$ Million) Table 213. Spain Pharmaceutical API and Intermediates Revenue (2021-2032) & (US$ Million) Table 214. Netherlands Pharmaceutical API and Intermediates Revenue (2021-2032) & (US$ Million) Table 215. Switzerland Pharmaceutical API and Intermediates Revenue (2021-2032) & (US$ Million) Table 216. Sweden Pharmaceutical API and Intermediates Revenue (2021-2032) & (US$ Million) Table 217. Poland Pharmaceutical API and Intermediates Revenue (2021-2032) & (US$ Million) Table 218. China Pharmaceutical API and Intermediates Revenue by Type (2021-2026) & (US$ Million) Table 219. China Pharmaceutical API and Intermediates Revenue by Type (2027-2032) & (US$ Million) Table 220. China Pharmaceutical API and Intermediates Sales by Type (2021-2026) & (Tons) Table 221. China Pharmaceutical API and Intermediates Sales by Type (2027-2032) & (Tons) Table 222. China Pharmaceutical API and Intermediates Sales Price by Type (2021-2026) & (US$/Ton) Table 223. China Pharmaceutical API and Intermediates Sales Price by Type (2027-2032) & (US$/Ton) Table 224. China Pharmaceutical API and Intermediates Revenue by Application (2021-2026) & (US$ Million) Table 225. China Pharmaceutical API and Intermediates Revenue by Application (2027-2032) & (US$ Million) Table 226. China Pharmaceutical API and Intermediates Sales by Application (2021-2026) & (Tons) Table 227. China Pharmaceutical API and Intermediates Sales by Application (2027-2032) & (Tons) Table 228. China Pharmaceutical API and Intermediates Sales Price by Application (2021-2026) & (US$/Ton) Table 229. China Pharmaceutical API and Intermediates Sales Price by Application (2027-2032) & (US$/Ton) Table 230. Asia Pharmaceutical API and Intermediates Revenue by Type (2021-2026) & (US$ Million) Table 231. Asia Pharmaceutical API and Intermediates Revenue by Type (2027-2032) & (US$ Million) Table 232. Asia Pharmaceutical API and Intermediates Sales by Type (2021-2026) & (Tons) Table 233. Asia Pharmaceutical API and Intermediates Sales by Type (2027-2032) & (Tons) Table 234. Asia Pharmaceutical API and Intermediates Sales Price by Type (2021-2026) & (US$/Ton) Table 235. Asia Pharmaceutical API and Intermediates Sales Price by Type (2027-2032) & (US$/Ton) Table 236. Asia Pharmaceutical API and Intermediates Revenue by Application (2021-2026) & (US$ Million) Table 237. Asia Pharmaceutical API and Intermediates Revenue by Application (2027-2032) & (US$ Million) Table 238. Asia Pharmaceutical API and Intermediates Sales by Application (2021-2026) & (Tons) Table 239. Asia Pharmaceutical API and Intermediates Sales by Application (2027-2032) & (Tons) Table 240. Asia Pharmaceutical API and Intermediates Sales Price by Application (2021-2026) & (US$/Ton) Table 241. Asia Pharmaceutical API and Intermediates Sales Price by Application (2027-2032) & (US$/Ton) Table 242. Asia Pharmaceutical API and Intermediates Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 243. Asia Pharmaceutical API and Intermediates Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 244. Asia Pharmaceutical API and Intermediates Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 245. Asia Pharmaceutical API and Intermediates Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 246. Asia Pharmaceutical API and Intermediates Sales by Country (2021-2026) & (Tons) Table 247. Asia Pharmaceutical API and Intermediates Sales by Country (2027-2032) & (Tons) Table 248. Asia Pharmaceutical API and Intermediates Sales Price by Country (2021-2026) & (US$/Ton) Table 249. Asia Pharmaceutical API and Intermediates Sales Price by Country (2027-2032) & (US$/Ton) Table 250. Japan Pharmaceutical API and Intermediates Revenue (2021-2032) & (US$ Million) Table 251. South Korea Pharmaceutical API and Intermediates Revenue (2021-2032) & (US$ Million) Table 252. India Pharmaceutical API and Intermediates Revenue (2021-2032) & (US$ Million) Table 253. Australia Pharmaceutical API and Intermediates Revenue (2021-2032) & (US$ Million) Table 254. Taiwan Pharmaceutical API and Intermediates Revenue (2021-2032) & (US$ Million) Table 255. Southeast Asia Pharmaceutical API and Intermediates Revenue (2021-2032) & (US$ Million) Table 256. SAMEA Pharmaceutical API and Intermediates Revenue by Type (2021-2026) & (US$ Million) Table 257. SAMEA Pharmaceutical API and Intermediates Revenue by Type (2027-2032) & (US$ Million) Table 258. SAMEA Pharmaceutical API and Intermediates Sales by Type (2021-2026) & (Tons) Table 259. SAMEA Pharmaceutical API and Intermediates Sales by Type (2027-2032) & (Tons) Table 260. SAMEA Pharmaceutical API and Intermediates Sales Price by Type (2021-2026) & (US$/Ton) Table 261. SAMEA Pharmaceutical API and Intermediates Sales Price by Type (2027-2032) & (US$/Ton) Table 262. SAMEA Pharmaceutical API and Intermediates Revenue by Application (2021-2026) & (US$ Million) Table 263. SAMEA Pharmaceutical API and Intermediates Revenue by Application (2027-2032) & (US$ Million) Table 264. SAMEA Pharmaceutical API and Intermediates Sales by Application (2021-2026) & (Tons) Table 265. SAMEA Pharmaceutical API and Intermediates Sales by Application (2027-2032) & (Tons) Table 266. SAMEA Pharmaceutical API and Intermediates Sales Price by Application (2021-2026) & (US$/Ton) Table 267. SAMEA Pharmaceutical API and Intermediates Sales Price by Application (2027-2032) & (US$/Ton) Table 268. SAMEA Pharmaceutical API and Intermediates Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 269. SAMEA Pharmaceutical API and Intermediates Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 270. SAMEA Pharmaceutical API and Intermediates Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 271. SAMEA Pharmaceutical API and Intermediates Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 272. SAMEA Pharmaceutical API and Intermediates Sales by Country (2021-2026) & (Tons) Table 273. SAMEA Pharmaceutical API and Intermediates Sales by Country (2027-2032) & (Tons) Table 274. SAMEA Pharmaceutical API and Intermediates Sales Price by Country (2021-2026) & (US$/Ton) Table 275. SAMEA Pharmaceutical API and Intermediates Sales Price by Country (2027-2032) & (US$/Ton) Table 276. Brazil Pharmaceutical API and Intermediates Revenue (2021-2032) & (US$ Million) Table 277. Argentina Pharmaceutical API and Intermediates Revenue (2021-2032) & (US$ Million) Table 278. Chile Pharmaceutical API and Intermediates Revenue (2021-2032) & (US$ Million) Table 279. Colombia Pharmaceutical API and Intermediates Revenue (2021-2032) & (US$ Million) Table 280. Peru Pharmaceutical API and Intermediates Revenue (2021-2032) & (US$ Million) Table 281. Saudi Arabia Pharmaceutical API and Intermediates Revenue (2021-2032) & (US$ Million) Table 282. Israel Pharmaceutical API and Intermediates Revenue (2021-2032) & (US$ Million) Table 283. UAE Pharmaceutical API and Intermediates Revenue (2021-2032) & (US$ Million) Table 284. Turkey Pharmaceutical API and Intermediates Revenue (2021-2032) & (US$ Million) Table 285. Iran Pharmaceutical API and Intermediates Revenue (2021-2032) & (US$ Million) Table 286. Egypt Pharmaceutical API and Intermediates Revenue (2021-2032) & (US$ Million) Table 287. Key Raw Materials Table 288. Raw Materials Key Suppliers Table 289. Pharmaceutical API and Intermediates Distributors List Table 290. Pharmaceutical API and Intermediates Customers List Table 291. Research Programs/Design for This Report Table 292. Authors List of This Report Table 293. Secondary Sources Table 294. Primary Sources List of Figures Figure 1. Pharmaceutical API and Intermediates Product Image Figure 2. Global Pharmaceutical API and Intermediates Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmaceutical API and Intermediates Market Size Share 2021 VS 2025 VS 2032 Figure . API Image Figure 1. Pharmaceutical Intermediates Image Figure 2. Global Pharmaceutical API and Intermediates Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmaceutical API and Intermediates Market Size Share 2021 VS 2025 VS 2032 Figure 4. Pharmaceutical Image Figure 5. Feed Image Figure 6. Food Image Figure 7. Cosmetics Image Figure 8. Health Products Image Figure 9. Global Pharmaceutical API and Intermediates Capacity, Capacity Utilization (2021-2032) & (Tons) Figure 10. Global Pharmaceutical API and Intermediates Production by Region: 2021 VS 2025 VS 2032 (Tons) Figure 11. Global Pharmaceutical API and Intermediates Production Market Share by Region: 2025 Versus 2032 Figure 12. Global Pharmaceutical API and Intermediates Production Market Share by Region (2021-2032) Figure 13. North America Pharmaceutical API and Intermediates Production Growth Rate (2021-2032) & (Tons) Figure 14. Europe Pharmaceutical API and Intermediates Production Growth Rate (2021-2032) & (Tons) Figure 15. China Pharmaceutical API and Intermediates Production Growth Rate (2021-2032) & (Tons) Figure 16. Japan Pharmaceutical API and Intermediates Production Growth Rate (2021-2032) & (Tons) Figure 17. Global Pharmaceutical API and Intermediates Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 18. Global Pharmaceutical API and Intermediates Revenue (2021-2032) & (US$ Million) Figure 19. Global Pharmaceutical API and Intermediates Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Pharmaceutical API and Intermediates Revenue Market Share by Region: 2025 Versus 2032 Figure 21. Global Pharmaceutical API and Intermediates Revenue Market Share by Region (2021-2032) Figure 22. Global Pharmaceutical API and Intermediates Sales (2021-2032) & (Tons) Figure 23. Global Pharmaceutical API and Intermediates Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 24. Global Pharmaceutical API and Intermediates Sales Market Share by Region (2021-2032) Figure 25. North America Pharmaceutical API and Intermediates Sales YoY (2021-2032) & (Tons) Figure 26. Europe Pharmaceutical API and Intermediates Sales YoY (2021-2032) & (Tons) Figure 27. China Pharmaceutical API and Intermediates Sales YoY (2021-2032) & (Tons) Figure 28. Asia (Excluding China) Pharmaceutical API and Intermediates Sales YoY (2021-2032) & (Tons) Figure 29. South America, Middle East and Africa Pharmaceutical API and Intermediates Sales YoY (2021-2032) & (Tons) Figure 30. Global Pharmaceutical API and Intermediates Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 31. Global Pharmaceutical API and Intermediates Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 32. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 33. Global Pharmaceutical API and Intermediates Revenue Market Share by Type (2021-2032) Figure 34. Global Pharmaceutical API and Intermediates Sales Market Share by Type (2021-2032) Figure 35. Global Pharmaceutical API and Intermediates Revenue Market Share by Application (2021-2032) Figure 36. Global Pharmaceutical API and Intermediates Sales Market Share by Application (2021-2032) Figure 37. North America Pharmaceutical API and Intermediates Revenue Share by Type (2021-2032) Figure 38. North America Pharmaceutical API and Intermediates Sales Share by Type (2021-2032) Figure 39. North America Pharmaceutical API and Intermediates Revenue Share by Application (2021-2032) Figure 40. North America Pharmaceutical API and Intermediates Sales Share by Application (2021-2032) Figure 41. North America Pharmaceutical API and Intermediates Revenue Share by Country (2021-2032) Figure 42. North America Pharmaceutical API and Intermediates Sales Share by Country (2021-2032) Figure 43. Europe Pharmaceutical API and Intermediates Revenue Share by Type (2021-2032) Figure 44. Europe Pharmaceutical API and Intermediates Sales Share by Type (2021-2032) Figure 45. Europe Pharmaceutical API and Intermediates Revenue Share by Application (2021-2032) Figure 46. Europe Pharmaceutical API and Intermediates Sales Share by Application (2021-2032) Figure 47. Europe Pharmaceutical API and Intermediates Revenue Share by Country (2021-2032) Figure 48. Europe Pharmaceutical API and Intermediates Sales Share by Country (2021-2032) Figure 49. China Pharmaceutical API and Intermediates Revenue Share by Type (2021-2032) Figure 50. China Pharmaceutical API and Intermediates Sales Share by Type (2021-2032) Figure 51. China Pharmaceutical API and Intermediates Revenue Share by Application (2021-2032) Figure 52. China Pharmaceutical API and Intermediates Sales Share by Application (2021-2032) Figure 53. Asia Pharmaceutical API and Intermediates Revenue Share by Type (2021-2032) Figure 54. Asia Pharmaceutical API and Intermediates Sales Share by Type (2021-2032) Figure 55. Asia Pharmaceutical API and Intermediates Revenue Share by Application (2021-2032) Figure 56. Asia Pharmaceutical API and Intermediates Sales Share by Application (2021-2032) Figure 57. Asia Pharmaceutical API and Intermediates Revenue Share by Country (2021-2032) Figure 58. Asia Pharmaceutical API and Intermediates Sales Share by Country (2021-2032) Figure 59. SAMEA Pharmaceutical API and Intermediates Revenue Share by Type (2021-2032) Figure 60. SAMEA Pharmaceutical API and Intermediates Sales Share by Type (2021-2032) Figure 61. SAMEA Pharmaceutical API and Intermediates Revenue Share by Application (2021-2032) Figure 62. SAMEA Pharmaceutical API and Intermediates Sales Share by Application (2021-2032) Figure 63. SAMEA Pharmaceutical API and Intermediat

Scope & coverage.

Types
  • API
  • Pharmaceutical Intermediates
Applications
  • Pharmaceutical
  • Feed
  • Food
  • Cosmetics
  • Health Products
Companies covered
  • Lonza
  • BASF
  • Patheon
  • Lianhetech
  • Jubilant
  • Catalent
  • ABA Chem
  • Actylis
  • Chiracon
  • Codexis
  • CordenPharma
  • Granules India
  • Pfizer
  • Porton
  • Sanofi
  • Jiuzhou Pharmaceutical
  • Menohua
  • Puluo Pharmaceutical
  • Stanley
  • Tianyu shares
  • Huahai Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pharmaceutical API and Intermediates Market by Type
  3. 1.2.1 Global Pharmaceutical API and Intermediates Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 API
  5. 1.2.3 Pharmaceutical Intermediates
  6. 1.3 Pharmaceutical API and Intermediates Market by Application
  7. 1.3.1 Global Pharmaceutical API and Intermediates Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Pharmaceutical
  9. 1.3.3 Feed
  10. 1.3.4 Food
  11. 1.3.5 Cosmetics
  12. 1.3.6 Health Products
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Pharmaceutical API and Intermediates Market Dynamics
  1. 2.1 Pharmaceutical API and Intermediates Industry Trends
  2. 2.2 Pharmaceutical API and Intermediates Industry Drivers
  3. 2.3 Pharmaceutical API and Intermediates Industry Opportunities and Challenges
  4. 2.4 Pharmaceutical API and Intermediates Industry Restraints
3 Global Pharmaceutical API and Intermediates Production Overview
  1. 3.1 Global Pharmaceutical API and Intermediates Production Capacity (2021-2032)
  2. 3.2 Global Pharmaceutical API and Intermediates Production by Region: 2021 VS 2025 VS 2032
  3. 3.3 Global Pharmaceutical API and Intermediates Production by Region
  4. 3.3.1 Global Pharmaceutical API and Intermediates Production by Region (2021-2026)
  5. 3.3.2 Global Pharmaceutical API and Intermediates Production by Region (2027-2032)
  6. 3.3.3 Global Pharmaceutical API and Intermediates Production Market Share by Region (2021-2032)
  7. 3.4 North America
  8. 3.5 Europe
  9. 3.6 China
  10. 3.7 Japan
4 Global Market Growth Prospects
  1. 4.1 Global Pharmaceutical API and Intermediates Revenue Estimates and Forecasts (2021-2032)
  2. 4.2 Global Pharmaceutical API and Intermediates Revenue by Region
  3. 4.2.1 Global Pharmaceutical API and Intermediates Revenue by Region: 2021 VS 2025 VS 2032
  4. 4.2.2 Global Pharmaceutical API and Intermediates Revenue by Region (2021-2026)
  5. 4.2.3 Global Pharmaceutical API and Intermediates Revenue by Region (2027-2032)
  6. 4.2.4 Global Pharmaceutical API and Intermediates Revenue Market Share by Region (2021-2032)
  7. 4.3 Global Pharmaceutical API and Intermediates Sales Estimates and Forecasts 2021-2032
  8. 4.4 Global Pharmaceutical API and Intermediates Sales by Region
  9. 4.4.1 Global Pharmaceutical API and Intermediates Sales by Region: 2021 VS 2025 VS 2032
  10. 4.4.2 Global Pharmaceutical API and Intermediates Sales by Region (2021-2026)
  11. 4.4.3 Global Pharmaceutical API and Intermediates Sales by Region (2027-2032)
  12. 4.4.4 Global Pharmaceutical API and Intermediates Sales Market Share by Region (2021-2032)
  13. 4.5 North America
  14. 4.6 Europe
  15. 4.7 China
  16. 4.8 Asia (Excluding China)
  17. 4.9 South America, Middle East and Africa
5 Market Competitive Landscape by Manufacturers
  1. 5.1 Global Pharmaceutical API and Intermediates Revenue by Manufacturers
  2. 5.1.1 Global Pharmaceutical API and Intermediates Revenue by Manufacturers (2021-2026)
  3. 5.1.2 Global Pharmaceutical API and Intermediates Revenue Market Share by Manufacturers (2021-2026)
  4. 5.1.3 Global Pharmaceutical API and Intermediates Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 5.2 Global Pharmaceutical API and Intermediates Sales by Manufacturers
  6. 5.2.1 Global Pharmaceutical API and Intermediates Sales by Manufacturers (2021-2026)
  7. 5.2.2 Global Pharmaceutical API and Intermediates Sales Market Share by Manufacturers (2021-2026)
  8. 5.2.3 Global Pharmaceutical API and Intermediates Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 5.3 Global Pharmaceutical API and Intermediates Sales Price by Manufacturers (2021-2026)
  10. 5.4 Global Pharmaceutical API and Intermediates Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 5.5 Global Pharmaceutical API and Intermediates Key Manufacturers Manufacturing Sites & Headquarters
  12. 5.6 Global Pharmaceutical API and Intermediates Manufacturers, Product Type & Application
  13. 5.7 Global Pharmaceutical API and Intermediates Manufacturers Commercialization Time
  14. 5.8 Market Competitive Analysis
  15. 5.8.1 Global Pharmaceutical API and Intermediates Market CR5 and HHI
  16. 5.8.2 2025 Pharmaceutical API and Intermediates Tier 1, Tier 2, and Tier 3
6 Pharmaceutical API and Intermediates Market by Type
  1. 6.1 Global Pharmaceutical API and Intermediates Revenue by Type
  2. 6.1.1 Global Pharmaceutical API and Intermediates Revenue by Type (2021-2032) & (US$ Million)
  3. 6.1.2 Global Pharmaceutical API and Intermediates Revenue Market Share by Type (2021-2032)
  4. 6.2 Global Pharmaceutical API and Intermediates Sales by Type
  5. 6.2.1 Global Pharmaceutical API and Intermediates Sales by Type (2021-2032) & (Tons)
  6. 6.2.2 Global Pharmaceutical API and Intermediates Sales Market Share by Type (2021-2032)
  7. 6.3 Global Pharmaceutical API and Intermediates Price by Type
7 Pharmaceutical API and Intermediates Market by Application
  1. 7.1 Global Pharmaceutical API and Intermediates Revenue by Application
  2. 7.1.1 Global Pharmaceutical API and Intermediates Revenue by Application (2021-2032) & (US$ Million)
  3. 7.1.2 Global Pharmaceutical API and Intermediates Revenue Market Share by Application (2021-2032)
  4. 7.2 Global Pharmaceutical API and Intermediates Sales by Application
  5. 7.2.1 Global Pharmaceutical API and Intermediates Sales by Application (2021-2032) & (Tons)
  6. 7.2.2 Global Pharmaceutical API and Intermediates Sales Market Share by Application (2021-2032)
  7. 7.3 Global Pharmaceutical API and Intermediates Price by Application
8 Company Profiles
  1. 8.1 Lonza
  2. 8.1.1 Lonza Company Information
  3. 8.1.2 Lonza Business Overview
  4. 8.1.3 Lonza Pharmaceutical API and Intermediates Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 8.1.4 Lonza Pharmaceutical API and Intermediates Product Portfolio
  6. 8.1.5 Lonza Recent Developments
  7. 8.2 BASF
  8. 8.2.1 BASF Company Information
  9. 8.2.2 BASF Business Overview
  10. 8.2.3 BASF Pharmaceutical API and Intermediates Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 8.2.4 BASF Pharmaceutical API and Intermediates Product Portfolio
  12. 8.2.5 BASF Recent Developments
  13. 8.3 Patheon
  14. 8.3.1 Patheon Company Information
  15. 8.3.2 Patheon Business Overview
  16. 8.3.3 Patheon Pharmaceutical API and Intermediates Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 8.3.4 Patheon Pharmaceutical API and Intermediates Product Portfolio
  18. 8.3.5 Patheon Recent Developments
  19. 8.4 Lianhetech
  20. 8.4.1 Lianhetech Company Information
  21. 8.4.2 Lianhetech Business Overview
  22. 8.4.3 Lianhetech Pharmaceutical API and Intermediates Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 8.4.4 Lianhetech Pharmaceutical API and Intermediates Product Portfolio
  24. 8.4.5 Lianhetech Recent Developments
  25. 8.5 Jubilant
  26. 8.5.1 Jubilant Company Information
  27. 8.5.2 Jubilant Business Overview
  28. 8.5.3 Jubilant Pharmaceutical API and Intermediates Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 8.5.4 Jubilant Pharmaceutical API and Intermediates Product Portfolio
  30. 8.5.5 Jubilant Recent Developments
  31. 8.6 Catalent
  32. 8.6.1 Catalent Company Information
  33. 8.6.2 Catalent Business Overview
  34. 8.6.3 Catalent Pharmaceutical API and Intermediates Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 8.6.4 Catalent Pharmaceutical API and Intermediates Product Portfolio
  36. 8.6.5 Catalent Recent Developments
  37. 8.7 ABA Chem
  38. 8.7.1 ABA Chem Company Information
  39. 8.7.2 ABA Chem Business Overview
  40. 8.7.3 ABA Chem Pharmaceutical API and Intermediates Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 8.7.4 ABA Chem Pharmaceutical API and Intermediates Product Portfolio
  42. 8.7.5 ABA Chem Recent Developments
  43. 8.8 Actylis
  44. 8.8.1 Actylis Company Information
  45. 8.8.2 Actylis Business Overview
  46. 8.8.3 Actylis Pharmaceutical API and Intermediates Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 8.8.4 Actylis Pharmaceutical API and Intermediates Product Portfolio
  48. 8.8.5 Actylis Recent Developments
  49. 8.9 Chiracon
  50. 8.9.1 Chiracon Company Information
  51. 8.9.2 Chiracon Business Overview
  52. 8.9.3 Chiracon Pharmaceutical API and Intermediates Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 8.9.4 Chiracon Pharmaceutical API and Intermediates Product Portfolio
  54. 8.9.5 Chiracon Recent Developments
  55. 8.10 Codexis
  56. 8.10.1 Codexis Company Information
  57. 8.10.2 Codexis Business Overview
  58. 8.10.3 Codexis Pharmaceutical API and Intermediates Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 8.10.4 Codexis Pharmaceutical API and Intermediates Product Portfolio
  60. 8.10.5 Codexis Recent Developments
  61. 8.11 CordenPharma
  62. 8.11.1 CordenPharma Company Information
  63. 8.11.2 CordenPharma Business Overview
  64. 8.11.3 CordenPharma Pharmaceutical API and Intermediates Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 8.11.4 CordenPharma Pharmaceutical API and Intermediates Product Portfolio
  66. 8.11.5 CordenPharma Recent Developments
  67. 8.12 Granules India
  68. 8.12.1 Granules India Company Information
  69. 8.12.2 Granules India Business Overview
  70. 8.12.3 Granules India Pharmaceutical API and Intermediates Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 8.12.4 Granules India Pharmaceutical API and Intermediates Product Portfolio
  72. 8.12.5 Granules India Recent Developments
  73. 8.13 Pfizer
  74. 8.13.1 Pfizer Company Information
  75. 8.13.2 Pfizer Business Overview
  76. 8.13.3 Pfizer Pharmaceutical API and Intermediates Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 8.13.4 Pfizer Pharmaceutical API and Intermediates Product Portfolio
  78. 8.13.5 Pfizer Recent Developments
  79. 8.14 Porton
  80. 8.14.1 Porton Company Information
  81. 8.14.2 Porton Business Overview
  82. 8.14.3 Porton Pharmaceutical API and Intermediates Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 8.14.4 Porton Pharmaceutical API and Intermediates Product Portfolio
  84. 8.14.5 Porton Recent Developments
  85. 8.15 Sanofi
  86. 8.15.1 Sanofi Company Information
  87. 8.15.2 Sanofi Business Overview
  88. 8.15.3 Sanofi Pharmaceutical API and Intermediates Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 8.15.4 Sanofi Pharmaceutical API and Intermediates Product Portfolio
  90. 8.15.5 Sanofi Recent Developments
  91. 8.16 Jiuzhou Pharmaceutical
  92. 8.16.1 Jiuzhou Pharmaceutical Company Information
  93. 8.16.2 Jiuzhou Pharmaceutical Business Overview
  94. 8.16.3 Jiuzhou Pharmaceutical Pharmaceutical API and Intermediates Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 8.16.4 Jiuzhou Pharmaceutical Pharmaceutical API and Intermediates Product Portfolio
  96. 8.16.5 Jiuzhou Pharmaceutical Recent Developments
  97. 8.17 Menohua
  98. 8.17.1 Menohua Company Information
  99. 8.17.2 Menohua Business Overview
  100. 8.17.3 Menohua Pharmaceutical API and Intermediates Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 8.17.4 Menohua Pharmaceutical API and Intermediates Product Portfolio
  102. 8.17.5 Menohua Recent Developments
  103. 8.18 Puluo Pharmaceutical
  104. 8.18.1 Puluo Pharmaceutical Company Information
  105. 8.18.2 Puluo Pharmaceutical Business Overview
  106. 8.18.3 Puluo Pharmaceutical Pharmaceutical API and Intermediates Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 8.18.4 Puluo Pharmaceutical Pharmaceutical API and Intermediates Product Portfolio
  108. 8.18.5 Puluo Pharmaceutical Recent Developments
  109. 8.19 Stanley
  110. 8.19.1 Stanley Company Information
  111. 8.19.2 Stanley Business Overview
  112. 8.19.3 Stanley Pharmaceutical API and Intermediates Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 8.19.4 Stanley Pharmaceutical API and Intermediates Product Portfolio
  114. 8.19.5 Stanley Recent Developments
  115. 8.20 Tianyu shares
  116. 8.20.1 Tianyu shares Company Information
  117. 8.20.2 Tianyu shares Business Overview
  118. 8.20.3 Tianyu shares Pharmaceutical API and Intermediates Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 8.20.4 Tianyu shares Pharmaceutical API and Intermediates Product Portfolio
  120. 8.20.5 Tianyu shares Recent Developments
  121. 8.21 Huahai Pharmaceutical
  122. 8.21.1 Huahai Pharmaceutical Company Information
  123. 8.21.2 Huahai Pharmaceutical Business Overview
  124. 8.21.3 Huahai Pharmaceutical Pharmaceutical API and Intermediates Sales, Revenue, Price and Gross Margin (2021-2026)
  125. 8.21.4 Huahai Pharmaceutical Pharmaceutical API and Intermediates Product Portfolio
  126. 8.21.5 Huahai Pharmaceutical Recent Developments
9 North America
  1. 9.1 North America Pharmaceutical API and Intermediates Market Size by Type
  2. 9.1.1 North America Pharmaceutical API and Intermediates Revenue by Type (2021-2032)
  3. 9.1.2 North America Pharmaceutical API and Intermediates Sales by Type (2021-2032)
  4. 9.1.3 North America Pharmaceutical API and Intermediates Price by Type (2021-2032)
  5. 9.2 North America Pharmaceutical API and Intermediates Market Size by Application
  6. 9.2.1 North America Pharmaceutical API and Intermediates Revenue by Application (2021-2032)
  7. 9.2.2 North America Pharmaceutical API and Intermediates Sales by Application (2021-2032)
  8. 9.2.3 North America Pharmaceutical API and Intermediates Price by Application (2021-2032)
  9. 9.3 North America Pharmaceutical API and Intermediates Market Size by Country
  10. 9.3.1 North America Pharmaceutical API and Intermediates Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 North America Pharmaceutical API and Intermediates Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 North America Pharmaceutical API and Intermediates Price by Country (2021-2032)
  13. 9.3.4 United States
  14. 9.3.5 Canada
  15. 9.3.6 Mexico
10 Europe
  1. 10.1 Europe Pharmaceutical API and Intermediates Market Size by Type
  2. 10.1.1 Europe Pharmaceutical API and Intermediates Revenue by Type (2021-2032)
  3. 10.1.2 Europe Pharmaceutical API and Intermediates Sales by Type (2021-2032)
  4. 10.1.3 Europe Pharmaceutical API and Intermediates Price by Type (2021-2032)
  5. 10.2 Europe Pharmaceutical API and Intermediates Market Size by Application
  6. 10.2.1 Europe Pharmaceutical API and Intermediates Revenue by Application (2021-2032)
  7. 10.2.2 Europe Pharmaceutical API and Intermediates Sales by Application (2021-2032)
  8. 10.2.3 Europe Pharmaceutical API and Intermediates Price by Application (2021-2032)
  9. 10.3 Europe Pharmaceutical API and Intermediates Market Size by Country
  10. 10.3.1 Europe Pharmaceutical API and Intermediates Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 10.3.2 Europe Pharmaceutical API and Intermediates Sales by Country (2021 VS 2025 VS 2032)
  12. 10.3.3 Europe Pharmaceutical API and Intermediates Price by Country (2021-2032)
  13. 10.3.4 Germany
  14. 10.3.5 France
  15. 10.3.6 U.K.
  16. 10.3.7 Italy
  17. 10.3.8 Russia
  18. 10.3.9 Spain
  19. 10.3.10 Netherlands
  20. 10.3.11 Switzerland
  21. 10.3.12 Sweden
11 China
  1. 11.1 China Pharmaceutical API and Intermediates Market Size by Type
  2. 11.1.1 China Pharmaceutical API and Intermediates Revenue by Type (2021-2032)
  3. 11.1.2 China Pharmaceutical API and Intermediates Sales by Type (2021-2032)
  4. 11.1.3 China Pharmaceutical API and Intermediates Price by Type (2021-2032)
  5. 11.2 China Pharmaceutical API and Intermediates Market Size by Application
  6. 11.2.1 China Pharmaceutical API and Intermediates Revenue by Application (2021-2032)
  7. 11.2.2 China Pharmaceutical API and Intermediates Sales by Application (2021-2032)
  8. 11.2.3 China Pharmaceutical API and Intermediates Price by Application (2021-2032)
12 Asia (Excluding China)
  1. 12.1 Asia Pharmaceutical API and Intermediates Market Size by Type
  2. 12.1.1 Asia Pharmaceutical API and Intermediates Revenue by Type (2021-2032)
  3. 12.1.2 Asia Pharmaceutical API and Intermediates Sales by Type (2021-2032)
  4. 12.1.3 Asia Pharmaceutical API and Intermediates Price by Type (2021-2032)
  5. 12.2 Asia Pharmaceutical API and Intermediates Market Size by Application
  6. 12.2.1 Asia Pharmaceutical API and Intermediates Revenue by Application (2021-2032)
  7. 12.2.2 Asia Pharmaceutical API and Intermediates Sales by Application (2021-2032)
  8. 12.2.3 Asia Pharmaceutical API and Intermediates Price by Application (2021-2032)
  9. 12.3 Asia Pharmaceutical API and Intermediates Market Size by Country
  10. 12.3.1 Asia Pharmaceutical API and Intermediates Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 Asia Pharmaceutical API and Intermediates Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 Asia Pharmaceutical API and Intermediates Price by Country (2021-2032)
  13. 12.3.4 Japan
  14. 12.3.5 South Korea
  15. 12.3.6 India
  16. 12.3.7 Australia
  17. 12.3.8 Taiwan
  18. 12.3.9 Southeast Asia
13 South America, Middle East and Africa
  1. 13.1 SAMEA Pharmaceutical API and Intermediates Market Size by Type
  2. 13.1.1 SAMEA Pharmaceutical API and Intermediates Revenue by Type (2021-2032)
  3. 13.1.2 SAMEA Pharmaceutical API and Intermediates Sales by Type (2021-2032)
  4. 13.1.3 SAMEA Pharmaceutical API and Intermediates Price by Type (2021-2032)
  5. 13.2 SAMEA Pharmaceutical API and Intermediates Market Size by Application
  6. 13.2.1 SAMEA Pharmaceutical API and Intermediates Revenue by Application (2021-2032)
  7. 13.2.2 SAMEA Pharmaceutical API and Intermediates Sales by Application (2021-2032)
  8. 13.2.3 SAMEA Pharmaceutical API and Intermediates Price by Application (2021-2032)
  9. 13.3 SAMEA Pharmaceutical API and Intermediates Market Size by Country
  10. 13.3.1 SAMEA Pharmaceutical API and Intermediates Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 13.3.2 SAMEA Pharmaceutical API and Intermediates Sales by Country (2021 VS 2025 VS 2032)
  12. 13.3.3 SAMEA Pharmaceutical API and Intermediates Price by Country (2021-2032)
  13. 13.3.4 Brazil
  14. 13.3.5 Argentina
  15. 13.3.6 Chile
  16. 13.3.7 Colombia
  17. 13.3.8 Peru
  18. 13.3.9 Saudi Arabia
  19. 13.3.10 Israel
  20. 13.3.11 UAE
  21. 13.3.12 Turkey
  22. 13.3.13 Iran
  23. 13.3.14 Egypt
14 Value Chain and Sales Channels Analysis
  1. 14.1 Pharmaceutical API and Intermediates Value Chain Analysis
  2. 14.1.1 Pharmaceutical API and Intermediates Key Raw Materials
  3. 14.1.2 Raw Materials Key Suppliers
  4. 14.1.3 Manufacturing Cost Structure
  5. 14.1.4 Pharmaceutical API and Intermediates Production Mode & Process
  6. 14.2 Pharmaceutical API and Intermediates Sales Channels Analysis
  7. 14.2.1 Direct Comparison with Distribution Share
  8. 14.2.2 Pharmaceutical API and Intermediates Distributors
  9. 14.2.3 Pharmaceutical API and Intermediates Customers
15 Concluding Insights
    16 Appendix
    1. 16.1 Reasons for Doing This Study
    2. 16.2 Research Methodology
    3. 16.3 Research Process
    4. 16.4 Authors List of This Report
    5. 16.5 Data Source
    6. 16.5.1 Secondary Sources
    7. 16.5.2 Primary Sources
    8. 16.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst